Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, with a minimal header and footer. This indicates that access to the study details is blocked and the content is not available for review.
    Difference
    18%
    Check dated 2026-09-23T01:22:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision label updated to Revision: v3.7.0, replacing Revision: v3.6.6; this reflects a page version update without altering the study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:20:59.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a minor page update. No study details or user-facing content were altered.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:27.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was issued, replacing v3.6.4. This reflects a backend/page-system update with no new study details or visible content changes indicated.
    Difference
    0.1%
    Check dated 2026-08-11T17:07:53.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.4). The revision history now lists v3.6.4 as the current version, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-28T13:27:30.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    New schedule milestones were added to the study record, including the latest update date and revised completion timelines that extend into 2027. Older milestone dates were removed, signaling an update to the study's expected timeline and status.
    Difference
    0.3%
    Check dated 2026-07-21T11:54:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.